In collaboration with Dr. Talia Golan’s team at the Cancer Research Center at Sheba Medical Center, a study, led by Prof. Malka Cohen-Armon and her team at TAU’s Sackler Faculty of Medicine have successfully eradicated the number of cancerous cells by up to 90% after two weeks of daily injections.
By MAAYAN JAFFE-HOFFMAN
A new treatment developed by Tel Aviv University could induce the destruction of pancreatic cancer cells, eradicating the number of cancerous cells by up to 90% after two weeks of daily injections of a small molecule known as PJ34.
Continue Reading »
Cancerous cells forming a lump in the pancreatic tissue.
A new protocol developed by Tel Aviv University researchers using nanotechnology that proved effective in preventing melanoma tumors in mice could lead to a major breakthrough in the treatment of far more dangerous skin cancers.
By Tsvi Sadan
Nature Nanotechnology published on August 5 a study led by Prof. Ronit Satchi-Fainaro, chair of the Department of Physiology and Pharmacology and head of the Laboratory for Cancer Research and Nanomedicine at Tel Aviv Universality’s Sackler Faculty of Medicine, and Prof. Helena Florindo of the University of Lisbon, while on sabbatical at the Satchi-Fainaro lab at Tel Aviv University.
Prof. Ronit Satchi-Fainaro – Screenshot: YouTube
Satchi-Fainaro’s research team, which also included Dr. Continue Reading »
Using a combination of several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that would kill cancer cells specifically, “We believe we will offer in a year’s time a complete cure for cancer,” says the chairman of AEBi.
By MAAYAN JAFFE-HOFFMAN
A small team of Israeli scientists think they might have found the first complete cure for cancer.
“We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, of a new treatment being developed by his company, Accelerated Evolution Biotechnologies Ltd. (AEBi), which was founded in 2000 in the ITEK incubator in the Weizmann Science Park. Continue Reading »
A team of international researchers from Harvard and Bar-Ilan University in Israel have discovered the specific mechanism that allows one’s immune system to attack cancer cells in a particularly efficient manner, and most effectively against lung cancer and melanoma.
By Arutz Sheva Staff
A new mechanism for activating the immune system against cancer cells allows immune cells to detect and destroy cancer cells better than before, according to a study recently published this week in the journal Nature.
The study was led by Prof. Nick Haining, of Harvard Medical School, and co-authored by Prof. Erez Levanon, doctoral student Ilana Buchumansky, of the Mina and Everard Goodman Faculty of Life Sciences at Bar-Ilan University, and an international team. Continue Reading »
The startup’s patented prototype scanner, BlueSky, is based on DOSI technology that scientist/researcher Ofir Aharon PhD invented, providing real-time data that shows early deterioration of skin lesions before they become pigmented.
By Abigail Klein Leichman
Ofir Aharon was in the last year of his PhD studies in electro-optics when his mother was diagnosed with melanoma.
Learning all he could about this deadly form of skin cancer, Aharon came to the conclusion that more than half of malignant melanoma lesions (usually, moles) fail to be diagnosed in the first two years after they appear – at a stage when treatment could be lifesaving. Continue Reading »
Being developed for oral use, not an injection, the ground-breaking treatment for acute myeloid leukemia will accomplish the work of 3-4 separate drugs, reduce cancer patients’ need for radical procedures and eliminate some unbearable side effects.
• The Hebrew University of Jerusalem researchers are trying to expand the drug’s use to other cancers.
By Ran Reznick, Erez Linn, Maytal Yasur Beit-Or & Israel Hayom Staff
Researchers at the Hebrew University of Jerusalem have recently developed a breakthrough biological drug to treat people suffering from acute myeloid leukemia.
AML is one of the most aggressive cancers, and while other cancers have benefited from new treatments, there has been little encouraging news for most leukemia patients for the past 40 years, the researchers said in a statement. Continue Reading »
Developed by researchers at Israel’s Weizmann Institute and Sourasky Medical Center, the U.S. Food and Drug Administration fast-tracked the approval for their cancer treatment Yescarta, based on technology that uses the patient’s immune system to destroy cancer cells.
• List price in U.S. for the personally tailored drug is $373,000.
By Hezi Sternlicht & Israel Hayom Staff
Kite Pharma, founded by Israeli-American Professor Arie Belldegrun in 2009, has announced that the U.S. Food and Drug Administration has granted regular approval for its cancer treatment Yescarta.
California-based Gilead Sciences bought Kite Pharma for $12 billion in August this year.
Professor Arie Belldegrun – Photo: Kite Pharma
The product, which was approved on a fast-track process, is based on innovative technology that recruits the body’s immune system to identify and destroy cancer cells. Continue Reading »
With the help of the Israeli gov’t, the IDF tracked down her family in Syria and covertly spirited her brother to Israel, so a bone-marrow transplant at Rambam Hospital was able to cure her cancer.
A six-year-old girl from Syria who was treated for her wound and a blood disease at Haifa’s Rambam Medical Center was discharged and sent home on Tuesday after her new Israeli friends held a farewell party and gave her with many gifts, including a first-grade backpack — in the hope that her school is still standing.
Photo Rambam Hospital
She was one of the 140 Syrian civilians — men, women and children — that Rambam doctors, nurses and other personnel have treated over the past three years of civil war there. Continue Reading »
Prof. Avigdor Scherz & Prof. Yoram Salomon of the Weizmann Institute develop a groundbreaking treatment for prostate cancer patients that targets the tumor without damaging genitalia, urinary tract, or general quality of life.
By Rotem Elizera
The incidence of prostate cancer, especially among men, in Israel has increased in the past two decades. However, Professor Avigdor Scherz and Professor Yoram Salomon of the Weizmann Institute have developed a groundbreaking treatment, bearing good news for the patients diagnosed with the deadly disease.
Special prostate cancer treatment. – Photo: Yariv Katz
Prostate cancer patients face a dilemma today: Undergoing prostate surgery and radiation, which often causes erectile dysfunction and urinary retention, or staying under “active surveillance,” which could allow the cancer to metastasize. Continue Reading »
Israeli professor from the Technion said, “Precisely because I am not a doctor, I was able to conceive such a unique development – an inexpensive & noninvasive system for diagnosing diseases based on breath.”
Prof. Hossam Haick of Haifa’s Technion-Israel Institute of Technology received the Humboldt Research Award in Germany and was also chosen as one of the 100 influential figures published by California’s Good Magazine over the weekend. He has been prominent, among other things in his development of devices to diagnose and monitor various types of cancers (lung, breast, colon, gastric, head and neck, ovarian, kidney and bladder malignancies) via breath samples. Continue Reading »
Israel’s groundbreaking new blood test, still in early stages, could save countless lives by detecting diseases such as pancreatic cancer, pancreatitis, diabetes, traumatic brain injury & multiple sclerosis early on.
By Arutz Sheva Staff
An experimental blood test may one day be able to detect a range of diseases including cancer and multiple sclerosis, based on signatures of DNA from dying cells, researchers said Monday.
Blood test (illustration) – iStock
Continue Reading »
The work, described in the Proceedings of the National Academy of Sciences, a peer-reviewed US journal, is still in its early stages, but opens up vast possibilities, the study authors said.
Innovative Israeli cure shows 94% of leukemia patients in clinical test in the U.S. exhibits signs of recovery.
By Israel Today Staff
An innovative Israeli-developed cure for leukemia that is currently being tested in the US is seeing amazing results.
The clinical tests have been run primarily on patients with advanced leukemia that were given only a matter of months to live. An astonishing 94 percent have reportedly shown improvement, and in more than half symptoms related to the cancer have disappeared all together.
Professor Zelig Eshhar
Professor Stanley Riddell of the University of Washington, who is running the tests, cautioned that much work remains to clarify the results of the study, and it is still unknown if the treatment managed to remove the cancer completely, or if it will return in the aforementioned patients. Continue Reading »
Hebrew University of Jerusalem students are working on micro-antenna that can be inserted into the stomach to detect & treat cancers too small to be treated with available methods.
By Yori Yalon
Students at the Hebrew University in Jerusalem are developing an innovative micro-antenna able to focus radiation at tiny tumors in the digestive tract.
An image of the innovative new antenna, which will revolutionize treatment of small tumors
Continue Reading »
The university noted that there is currently no treatment for tumors in the early stages of cancer, when they measure less than 5 millimeters (0.19 inches). The new antenna would eliminate the need to wait for the tumors to grow big enough to be treated, as well as eliminate the need for complicated, invasive surgery.
Doctors at Maccabi Health Services have developed a simple blood test for early detection of Israel’s 2nd-deadliest cancer, to replace the previous unpleasant procedures of colonoscopies & collecting stool samples.
Maccabi Health Services has developed a new noninvasive procedure to detect early signs of colon cancer.
Doctors hope new noninvasive technique to determine signs of colon cancer will lead many people to get tested who avoided the uncomfortable tests previously offered – Photo: Liquidlibrary
Colon cancer is the second most common and deadly form of cancer in Israel, with 3,200 new cases diagnosed and 1,300 deaths resulting from it in 2012. Continue Reading »